Ra Capital Management, L.P. Eye Point Pharmaceuticals, Inc. Transaction History

Ra Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$19.93 - $29.71 $18.7 Million - $27.9 Million	938,591 New	938,591 $19.4 Million
Q4 2021 Feb 14, 2022	BUY	$10.18 - $18.4 $11.8 Million - $21.3 Million	1,160,000 Added 52.48%	3,370,506 $41.3 Million
Q3 2021 Nov 15, 2021	BUY	$7.51 - $11.72 $7.21 Million - $11.3 Million	960,506 Added 76.84%	2,210,506 $23 Million
Q1 2021 May 17, 2021	BUY	$8.89 - $14.92 $11.1 Million - $18.7 Million	1,250,000 New	1,250,000 $12.7 Million

176

53.9M

764K

1.57M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $281M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.